HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Carlo Genova Selected Research
Carlo Genova Research Topics
Disease
62
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 06/2012
39
Neoplasms (Cancer)
08/2022 - 07/2012
18
Lung Neoplasms (Lung Cancer)
03/2022 - 07/2012
7
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2022 - 07/2014
6
Disease Progression
03/2021 - 06/2012
5
Neoplasm Metastasis (Metastasis)
01/2022 - 10/2016
5
Circulating Neoplastic Cells
12/2019 - 01/2014
4
COVID-19
08/2022 - 01/2020
4
Breast Neoplasms (Breast Cancer)
01/2021 - 01/2015
3
Malignant Mesothelioma
04/2022 - 01/2016
3
Adenocarcinoma of Lung
10/2016 - 06/2015
2
Inflammation (Inflammations)
01/2022 - 06/2021
2
Melanoma (Melanoma, Malignant)
01/2019 - 07/2012
2
Carcinoma (Carcinomatosis)
01/2019 - 01/2018
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2016 - 01/2016
1
Infections
08/2022
1
Asymptomatic Infections
08/2022
1
Gastritis
01/2022
1
Pneumonia (Pneumonitis)
01/2022
1
Sarcoma (Soft Tissue Sarcoma)
03/2021
1
Persistent Infection
01/2021
1
Brain Neoplasms (Brain Tumor)
01/2021
1
Hodgkin Disease (Hodgkin's Disease)
01/2021
1
Second Primary Neoplasms (Neoplasms, Second)
01/2021
1
Obesity
10/2020
1
Overweight
10/2020
1
Thyroid Diseases (Thyroid Disease)
01/2020
1
Hypertension (High Blood Pressure)
01/2020
1
Chronic Obstructive Pulmonary Disease (COPD)
01/2020
Drug/Important Bio-Agent (IBA)
20
Immune Checkpoint Inhibitors
IBA
03/2022 - 01/2018
13
Biomarkers (Surrogate Marker)
IBA
01/2022 - 01/2014
12
Nivolumab
IBA
06/2021 - 01/2018
6
Tyrosine Kinase Inhibitors
IBA
05/2021 - 08/2014
6
pembrolizumab
IBA
01/2021 - 10/2020
5
Proteins (Proteins, Gene)
FDA Link
01/2021 - 10/2016
5
Monoclonal Antibodies
IBA
01/2021 - 07/2012
4
Platinum
IBA
03/2022 - 01/2018
4
Biological Products
IBA
01/2022 - 10/2014
4
Ligands
IBA
01/2022 - 01/2019
4
ErbB Receptors (EGF Receptor)
IBA
05/2021 - 09/2015
4
B7-H1 Antigen
IBA
01/2021 - 01/2019
4
MicroRNAs (MicroRNA)
IBA
12/2019 - 01/2016
4
Cell-Free Nucleic Acids
IBA
07/2019 - 12/2015
4
DNA (Deoxyribonucleic Acid)
IBA
03/2019 - 12/2015
4
Erlotinib Hydrochloride (CP 358,774)
FDA Link
12/2018 - 06/2012
3
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
01/2022 - 11/2017
3
Pharmaceutical Preparations
IBA
01/2021 - 08/2013
3
Pemetrexed (MTA)
FDA Link
12/2018 - 08/2013
3
Afatinib
IBA
12/2018 - 04/2014
3
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
01/2018 - 01/2016
2
Anaplastic Lymphoma Kinase
IBA
01/2022 - 03/2021
2
osimertinib
IBA
05/2021 - 01/2019
2
CTLA-4 Antigen
IBA
01/2021 - 07/2012
2
Phosphotransferases (Kinase)
IBA
01/2020 - 01/2016
2
Messenger RNA (mRNA)
IBA
01/2019 - 01/2018
2
Antibodies
IBA
01/2019 - 01/2018
2
Circulating Tumor DNA
IBA
01/2019 - 11/2017
2
Vaccines
IBA
01/2018 - 07/2012
2
Oxygen (Dioxygen)
IBA
01/2018 - 08/2013
2
necitumumab
IBA
01/2018 - 01/2016
2
Solutions
IBA
01/2017 - 01/2016
2
Formaldehyde (Formol)
FDA Link
01/2016 - 12/2015
2
Paraffin
IBA
01/2016 - 12/2015
2
Gefitinib (Iressa)
FDA Link
06/2015 - 06/2012
2
Ipilimumab
IBA
07/2014 - 07/2012
1
Carboplatin (JM8)
FDA Link
Generic
03/2022
1
Bevacizumab (Avastin)
FDA Link
03/2022
1
atezolizumab
IBA
03/2022
1
Etoposide (VP 16)
FDA Link
Generic
03/2022
1
brigatinib
IBA
01/2022
1
C-Reactive Protein
IBA
01/2022
1
Procalcitonin
IBA
01/2022
1
human ERBB2 protein
IBA
03/2021
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
03/2021
1
Immunoconjugates (Immunoconjugate)
IBA
01/2021
1
Brentuximab Vedotin
IBA
01/2021
1
Ado-Trastuzumab Emtansine
IBA
01/2021
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2021
1
Antigens
IBA
01/2021
1
Cytotoxins (Cytolysins)
IBA
01/2021
1
Hormones (Hormone)
IBA
01/2021
1
Immunologic Factors (Immunomodulators)
IBA
01/2021
1
Long-Acting Thyroid Stimulator (LATS)
IBA
01/2021
1
Estrogen Receptors
IBA
01/2021
1
Gonadal Steroid Hormones (Sex Hormones)
IBA
01/2021
1
Steroids
IBA
01/2021
1
Protein Isoforms (Isoforms)
IBA
01/2021
1
Proton Pump Inhibitors
IBA
01/2021
1
Cytostatic Agents
IBA
01/2021
1
Adenosine Diphosphate Ribose (ADP-Ribose)
IBA
04/2020
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
04/2020
1
ORALIT (ORS)
IBA
01/2020
Therapy/Procedure
23
Therapeutics
08/2022 - 06/2012
17
Immunotherapy
04/2022 - 01/2014
11
Drug Therapy (Chemotherapy)
03/2022 - 08/2014
3
Precision Medicine
01/2022 - 01/2015
2
Lasers (Laser)
01/2018 - 01/2017
1
Radiotherapy
01/2021
1
Critical Care (Surgical Intensive Care)
01/2020
1
Continuity of Patient Care
01/2020